New Hope For Amputees: OPRA Prosthetic Gets FDA Nod
Executive Summary
The Osseoanchored Prostheses for the Rehabilitation of Amputees Implant System – or OPRA – anchors to an amputee’s thigh bone, allowing it to be used in patients for whom conventional socketed prosthetics don’t work.
You may also be interested in...
Securing FDA Approval For Novel OPRA Prosthetic Wasn’t A ‘Slam Dunk.’ Here’s How Start-Up Integrum Made It Through The PMA Maze
In this case study, experts at the law firm Hogan Lovells and device maker Integrum AB tell Medtech Insight about some hurdles the Swedish start-up jumped when trying to win premarket approval from the US FDA for its Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System.
New Product Briefs
Product announcements from Medtronic, Alere, St. Jude Medical and Integrum.
For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component
Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.